title: Characteristics of cardiac allograft vasculopathy induced by immunomodulation in the miniature Swine.
abstract: OBJECTIVE
  We aimed to develop swine cardiac transplantation model for study of cardiac allograft vasculopathy (CAV) and to characterize the mechanisms of its formation.
  
  
  METHODS
  Heterotropic cardiac transplantation was performed in swine leukocyte antigen mismatched miniature swine, and CAV was induced by immunomodulation by cyclosporine A (CyA). Histology and immunohistochemistry were performed to identify cellular components of CAV. Fluorescence in situ hybridization (FISH) was developed for detection of 1 and Y-chromosome for identification of cell origin in the female donor to the male recipient heart transplantation model.
  
  
  RESULTS
  CAV was successfully developed by immunomodulation of CyA. Severity of CAV revealed more prominent in the distal epicardial coronary arteries than proximal coronary arteries. Phenotype of the SMCs proliferated in the intimal thickening of CAV were mostly embryonal/secretory type. Our new chromosome specific probes for FISH method were useful for discrimination of sex of each cell, and proliferated SMCs were revealed to be mainly donor origin.
  
  
  CONCLUSIONS
  CAV mimicking human heart transplantation can be developed by appropriate immunomodulation in the swine. In swine CAV, proliferated SMCs seen in the intimal thickening were demonstrated to be from the donor origin.
authors.affiliation: Department of Cardiovascular Surgery, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
authors.forename: Jun
authors.initials: J
authors.lastname: Amano
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Akashima
authors.forename: Takamitsu
authors.initials: T
authors.lastname: Terasaki
authors.forename: Yuko
authors.initials: Y
authors.lastname: Wada
authors.forename: Midori
authors.initials: M
authors.lastname: Ito-Amano
authors.forename: Jun-Ichi
authors.initials: J
authors.lastname: Suzuki
authors.forename: Mitsuaki
authors.initials: M
authors.lastname: Isobe
mesh_terms: D000818:Animals; D049109:Cell Proliferation; D003324:Coronary Artery Disease / Q000139:chemically induced / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D003331:Coronary Vessels / Q000276:immunology* / Q000473:pathology; D016572:Cyclosporine; D004195:Disease Models, Animal; D005819:Genetic Markers; D016027:Heart Transplantation / Q000009:adverse effects*; D006648:Histocompatibility; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D007166:Immunosuppressive Agents; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000276:immunology / Q000473:pathology; D032389:Myocytes, Smooth Muscle / Q000276:immunology / Q000473:pathology; D012720:Severity of Illness Index; D013552:Swine; D013556:Swine, Miniature; D013997:Time Factors; D016042:Transplantation, Heterotopic; D014998:Y Chromosome
chemical_list: D005819:Genetic Markers; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D007166:Immunosuppressive Agents; C438668:swine leukocyte antigen; D016572:Cyclosporine
references.citation: Cardiovasc Res. 1988 Apr;22(4):296-9
references.pmid: 3058303
references.citation: Prog Allergy. 1986;38:123-58
references.pmid: 3088580
references.citation: Am J Pathol. 1993 Apr;142(4):975-80
references.pmid: 7682765
references.citation: Circulation. 1996 Oct 1;94(7):1655-64
references.pmid: 8840858
references.citation: J Heart Lung Transplant. 2013 Apr;32(4):454-60
references.pmid: 23498165
references.citation: J Heart Lung Transplant. 2004 Apr;23(4):427-35
references.pmid: 15063402
references.citation: Front Med. 2011 Sep;5(3):248-53
references.pmid: 21964706
references.citation: J Thorac Cardiovasc Surg. 1997 Jan;113(1):19-25
references.pmid: 9011689
references.citation: Circ J. 2013;77(5):1097-110
references.pmid: 23614963
references.citation: N Engl J Med. 2002 Jan 3;346(1):5-15
references.pmid: 11777997
references.citation: J Thorac Cardiovasc Surg. 1996 Jun;111(6):1230-9
references.pmid: 8642825
references.citation: Circulation. 2002 Jul 2;106(1):17-9
references.pmid: 12093763
references.citation: J Clin Invest. 2001 Jun;107(11):1411-22
references.pmid: 11390423
references.citation: Transplantation. 1998 Feb 15;65(3):304-13
references.pmid: 9484744
references.citation: Transpl Int. 2003 Jun;16(6):367-75
references.pmid: 12756523
references.citation: Circulation. 2006 Oct 10;114(15):1599-607
references.pmid: 17015796
references.citation: J Heart Lung Transplant. 1994 Sep-Oct;13(5):824-33
references.pmid: 7803423
references.citation: J Cardiovasc Transl Res. 2013 Apr;6(2):263-77
references.pmid: 23135991
references.citation: J Heart Transplant. 1989 Sep-Oct;8(5):349-59
references.pmid: 2795279
references.citation: Ann N Y Acad Sci. 1990;598:143-58
references.pmid: 2123377
references.citation: JACC Cardiovasc Interv. 2010 Apr;3(4):367-77
references.pmid: 20398862
references.citation: J Biol Chem. 1991 Feb 25;266(6):3768-73
references.pmid: 1995631
references.citation: Ann Thorac Cardiovasc Surg. 2005 Dec;11(6):386-90
references.pmid: 16401987
references.citation: Curr Gene Ther. 2004 Jun;4(2):145-52
references.pmid: 15180582